Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, intermediates, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitisers, antiseptics, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was incorporated in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
NSE
Unprofitable
Unprofitable
44B
Biotechnology
Next Earning date - 11 Aug 2025
44B
Biotechnology
Next Earning date - 11 Aug 2025
Relative Strenght
Volume Buzz
-91%Earning Acce
NoDist 52w H.
10%